170 related articles for article (PubMed ID: 26553674)
1. Communication Challenges During the Development and Introduction of a New Meningococcal Vaccine in Africa.
Berlier M; Barry R; Shadid J; Sirica C; Brunier A; Hasan H; Bouma E
Clin Infect Dis; 2015 Nov; 61 Suppl 5(Suppl 5):S451-8. PubMed ID: 26553674
[TBL] [Abstract][Full Text] [Related]
2. From Epidemic Meningitis Vaccines for Africa to the Meningitis Vaccine Project.
Aguado MT; Jodar L; Granoff D; Rabinovich R; Ceccarini C; Perkin GW
Clin Infect Dis; 2015 Nov; 61 Suppl 5(Suppl 5):S391-5. PubMed ID: 26553665
[TBL] [Abstract][Full Text] [Related]
3. Documenting the Results of a Successful Partnership: A New Meningococcal Vaccine for Africa.
Okwo-Bele JM; LaForce FM; Borrow R; Preziosi MP
Clin Infect Dis; 2015 Nov; 61 Suppl 5(Suppl 5):S389-90. PubMed ID: 26553664
[No Abstract] [Full Text] [Related]
4. Introduction and Rollout of a New Group A Meningococcal Conjugate Vaccine (PsA-TT) in African Meningitis Belt Countries, 2010-2014.
Djingarey MH; Diomandé FV; Barry R; Kandolo D; Shirehwa F; Lingani C; Novak RT; Tevi-Benissan C; Perea W; Preziosi MP; LaForce FM
Clin Infect Dis; 2015 Nov; 61 Suppl 5(Suppl 5):S434-41. PubMed ID: 26553672
[TBL] [Abstract][Full Text] [Related]
5. Technical Development of a New Meningococcal Conjugate Vaccine.
Frasch CE; Kapre SV; Lee CH; Préaud JM
Clin Infect Dis; 2015 Nov; 61 Suppl 5(Suppl 5):S404-9. PubMed ID: 26553667
[TBL] [Abstract][Full Text] [Related]
6. Lessons from the Meningitis Vaccine Project.
LaForce FM; Djingarey M; Viviani S; Preziosi MP
Viral Immunol; 2018 Mar; 31(2):109-113. PubMed ID: 29116892
[TBL] [Abstract][Full Text] [Related]
7. Developmental strategy for a new Group A meningococcal conjugate vaccine (MenAfriVac
Kulkarni PS; Jadhav SS; LaForce FM
Hum Vaccin Immunother; 2018 May; 14(5):1103-1106. PubMed ID: 29048988
[TBL] [Abstract][Full Text] [Related]
8. A Vaccine Meets Its Promise: Success in Controlling Epidemic Meningitis in Sub-Saharan Africa.
Sambo L; Chan M; Davis S; Lake A; Berkley S; Poonawalla C; Elias CJ
Clin Infect Dis; 2015 Nov; 61 Suppl 5(Suppl 5):S387-8. PubMed ID: 26553663
[No Abstract] [Full Text] [Related]
9. Community Perspectives Associated With the African PsA-TT (MenAfriVac) Vaccine Trials.
Idoko OT; Diallo A; Sow SO; Hodgson A; Akinsola A; Diarra B; Haidara FC; Ansah PO; Kampmann B; Bouma E; Preziosi MP; Enwere GC
Clin Infect Dis; 2015 Nov; 61 Suppl 5(Suppl 5):S416-21. PubMed ID: 26553669
[TBL] [Abstract][Full Text] [Related]
10. Regulatory Pathways That Facilitated Timely Registration of a New Group A Meningococcal Conjugate Vaccine for Africa's Meningitis Belt Countries.
Dellepiane N; Akanmori BD; Gairola S; Jadhav SS; Parker C; Rodriguez C; Srivastava S
Clin Infect Dis; 2015 Nov; 61 Suppl 5(Suppl 5):S428-33. PubMed ID: 26553671
[TBL] [Abstract][Full Text] [Related]
11. Risk Assessment and Meningococcal A Conjugate Vaccine Introduction in Africa: The District Prioritization Tool.
Cibrelus L; Lingani C; Fernandez K; Djingarey MH; Perea WA; Hugonnet S
Clin Infect Dis; 2015 Nov; 61 Suppl 5(Suppl 5):S442-50. PubMed ID: 26553673
[TBL] [Abstract][Full Text] [Related]
12. [Meningococcal meningitis epidemics in sub-Saharan Africa and the meningococcal A conjugate vaccine].
Nicolas P
Med Sante Trop; 2012; 22(3):246-58. PubMed ID: 23186941
[TBL] [Abstract][Full Text] [Related]
13. The Evolution of the Meningitis Vaccine Project.
Tiffay K; Jodar L; Kieny MP; Socquet M; LaForce FM
Clin Infect Dis; 2015 Nov; 61 Suppl 5(Suppl 5):S396-403. PubMed ID: 26553666
[TBL] [Abstract][Full Text] [Related]
14. A rebuttal: epidemic and endemic meningococcal meningitis in sub-Saharan Africa can be prevented now by routine immunization with group A meningococcal capsular polysaccharide vaccine.
Robbins JB; Schneerson R; Gotschlich EC
Pediatr Infect Dis J; 2000 Oct; 19(10):945-53. PubMed ID: 11055594
[No Abstract] [Full Text] [Related]
15. Epidemic meningitis control in countries of the African meningitis belt, 2016.
Wkly Epidemiol Rec; 2017 Mar; 92(13):145-54. PubMed ID: 28361528
[No Abstract] [Full Text] [Related]
16. The Meningitis Vaccine Project.
LaForce FM; Konde K; Viviani S; Préziosi MP
Vaccine; 2007 Sep; 25 Suppl 1():A97-100. PubMed ID: 17521780
[TBL] [Abstract][Full Text] [Related]
17. Meningococcal carriage in the African meningitis belt.
MenAfriCar Consortium
Trop Med Int Health; 2013 Aug; 18(8):968-78. PubMed ID: 23682910
[TBL] [Abstract][Full Text] [Related]
18. Serogroup A meningococcal conjugate (PsA-TT) vaccine coverage and measles vaccine coverage in Burkina Faso--implications for introduction of PsA-TT into the Expanded Programme on Immunization.
Meyer SA; Kambou JL; Cohn A; Goodson JL; Flannery B; Medah I; Messonnier N; Novak R; Diomande F; Djingarey MH; Clark TA; Yameogo I; Fall A; Wannemuehler K
Vaccine; 2015 Mar; 33(12):1492-8. PubMed ID: 25636915
[TBL] [Abstract][Full Text] [Related]
19. Emergency vaccination against epidemic meningitis in Ghana: implications for the control of meningococcal disease in West Africa.
Woods CW; Armstrong G; Sackey SO; Tetteh C; Bugri S; Perkins BA; Rosenstein NE
Lancet; 2000 Jan; 355(9197):30-3. PubMed ID: 10615888
[TBL] [Abstract][Full Text] [Related]
20. Response thresholds for epidemic meningitis in sub-Saharan Africa following the introduction of MenAfriVac®.
Trotter CL; Cibrelus L; Fernandez K; Lingani C; Ronveaux O; Stuart JM
Vaccine; 2015 Nov; 33(46):6212-7. PubMed ID: 26463444
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
